SCYX - Scynexis Inc - SEC Form 4 Insider Trading Screener
22 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
| P | 19 | +3 | +9 | -10 | +12 |
X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Insider Title |
Trade Type |
Share Price |
Shares Traded |
Shares Owned |
Own chg |
Value Traded |
1d ret |
1w ret |
1m ret |
6m ret |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2017-06-21 | SCYX | Hastings David C | Dir | P - Purchase | $1.75 | +20,000 | 20,000 | New | +$35,000 | ||||||
2017-05-12 | SCYX | Taglietti Marco | CEO | P - Purchase | $1.69 | +25,000 | 277,000 | +10% | +$42,250 | ||||||
2017-05-12 | SCYX | Angulo Gonzalez David | Chief Medical Officer | P - Purchase | $1.70 | +15,000 | 62,000 | +32% | +$25,500 | ||||||
2016-12-21 | SCYX | Taglietti Marco | CEO | P - Purchase | $3.30 | +25,000 | 251,000 | +11% | +$82,500 | +3 | -1 | -6 | |||
2016-12-16 | SCYX | Angulo Gonzalez David | Chief Medical Officer | P - Purchase | $3.25 | +4,000 | 46,000 | +10% | +$13,000 | +3 | +9 | +3 | |||
2016-09-15 | SCYX | Machado Patrick | Dir | P - Purchase | $2.94 | +40,000 | 60,000 | +200% | +$117,600 | +11 | +21 | +33 | +3 | ||
| M | 2016-06-29 | SCYX | Angulo Gonzalez David | Chief Medical Officer | P - Purchase | $2.22 | +36,950 | 41,000 | +912% | +$82,159 | +1 | +2 | -8 | +49 | |
| D | 2016-06-24 | SCYX | Machado Clarence Patrick | Dir | P - Purchase | $2.39 | +20,000 | 20,000 | New | +$47,800 | +4 | +6 | +1 | +66 | |
| D | 2016-06-24 | SCYX | Francois Eric | CFO | P - Purchase | $2.39 | +15,000 | 15,000 | New | +$35,850 | +4 | +6 | +1 | +66 | |
| D | 2016-06-24 | SCYX | Taglietti Marco | CEO | P - Purchase | $2.39 | +100,000 | 225,000 | +80% | +$239,000 | +4 | +6 | +1 | +66 | |
| D | 2016-06-24 | SCYX | Macdonald Guy | Dir | P - Purchase | $2.39 | +40,000 | 40,000 | New | +$95,600 | +4 | +6 | +1 | +66 | |
2016-05-25 | SCYX | Taglietti Marco | CEO | P - Purchase | $3.20 | +246 | 125,000 | 0% | +$787 | +10 | +21 | -35 | +12 | ||
2016-05-25 | SCYX | Hanham Ann | Dir | P - Purchase | $3.64 | +4,225 | 4,225 | New | +$15,379 | +10 | +21 | -35 | +12 | ||
2016-05-25 | SCYX | Taglietti Marco | CEO | P - Purchase | $3.26 | +5,754 | 124,754 | +5% | +$18,758 | +10 | +21 | -35 | +12 | ||
2016-05-24 | SCYX | Taglietti Marco | CEO | P - Purchase | $3.37 | +5,500 | 119,000 | +5% | +$18,535 | +2 | +27 | -33 | +13 | ||
| M | 2016-05-20 | SCYX | Taglietti Marco | CEO | P - Purchase | $3.14 | +7,500 | 113,500 | +7% | +$23,580 | 0 | +22 | -31 | +12 | |
2016-05-19 | SCYX | Taglietti Marco | CEO | P - Purchase | $3.07 | +6,000 | 106,000 | +6% | +$18,420 | +2 | +10 | -12 | +18 | ||
| M | 2015-11-23 | SCYX | Taglietti Marco | CEO | P - Purchase | $6.79 | +22,733 | 100,000 | +29% | +$154,434 | -5 | 0 | -11 | -52 | |
2015-09-15 | SCYX | Angulo Gonzalez David | Chief Medical Officer | P - Purchase | $7.00 | +3,000 | 3,000 | New | +$21,000 | -5 | -5 | -4 | -43 | ||
2015-08-31 | SCYX | Taglietti Marco | CEO | P - Purchase | $7.82 | +25,000 | 77,267 | +48% | +$195,500 | +2 | +7 | -2 | -31 | ||
| M | 2015-08-27 | SCYX | Taglietti Marco | CEO | P - Purchase | $7.08 | +2,267 | 52,267 | +5% | +$16,060 | -6 | -5 | -7 | -35 | |
| M | 2015-08-25 | SCYX | Taglietti Marco | CEO | P - Purchase | $7.07 | +50,000 | 50,000 | New | +$353,300 | +4 | -5 | -2 | -34 |
Real-time CSV? Options? Alerts? Contact us!
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |